Zheyao Gu

Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits

Objective To evaluate the anatomical and functional outcomes of faricimab in the treatment of naïve and refractory diabetic macular edema (DME) and to investigate OCT biomarkers associated with visual outcomes. Methods This retrospective real-world study included eyes with DME tr...